Lledo Belén, Turienzo Azahara, Ortiz Jose A, Morales Ruth, Ten Jorge, Llácer Joaquin, Bernabeu Rafael
Instituto Bernabeu Biotech, Avda. Albufereta, 31, 03016, Alicante, Spain,
J Assist Reprod Genet. 2014 Feb;31(2):169-72. doi: 10.1007/s10815-013-0147-2. Epub 2013 Dec 11.
Investigate whether R72P on p53 gene polymorphism has a higher prevalence among women with a history of recurrent implantation failure (RIF) and pregnancy loss (RPL) and its influence in their IVF cycle outcome.
p53 polymorphism R72P has been studied in 181 women. The control group included 83 oocyte donors. In the study group 98 women were included: 44 with RIF and 54 with RPL. From the study group, 76 patients underwent IVF-cycles (55 RPL and 21 RIF).
The frequency of PP genotypes on p53 among RIF was 11.4% compared with 18.5% for RPL and 6% in controls (p < 0.01). There were no significant differences with respect to patient characteristics. Significant differences were reported in pregnancy rate (69.4% for RR/RP and 33.3% for PP; p < 0.05), embryo implantation rate (33.3% for RR/RP and 7.3% for PP; p < 0.05) and ongoing pregnancy rate (53.1% for RR/RP and 14.3% for PP; p < 0.05) among RIF and RPL.
This investigation reveals that in RIF and RPL patients R72P on p53 gene is more prevalent than fertile population. Moreover, patients carrying a PP genotype on p53 codon 72 will have less chance to achieve an ongoing pregnancy. This information together with some additional markers will allow development of diagnostic tests for detects risk for RIF and RPL before infertility treatment is initiated.
研究p53基因多态性R72P在有反复种植失败(RIF)和复发性流产(RPL)病史的女性中是否具有更高的发生率,以及其对体外受精(IVF)周期结局的影响。
对181名女性进行了p53多态性R72P的研究。对照组包括83名卵母细胞捐赠者。研究组纳入98名女性:44名有反复种植失败,54名有复发性流产。研究组中,76例患者接受了IVF周期治疗(55例复发性流产和21例反复种植失败)。
反复种植失败患者中p53基因PP基因型的频率为11.4%,而复发性流产患者为18.5%,对照组为6%(p<0.01)。患者特征方面无显著差异。反复种植失败和复发性流产患者在妊娠率(RR/RP为69.4%,PP为33.3%;p<0.05)、胚胎着床率(RR/RP为33.3%,PP为7.3%;p<0.05)和持续妊娠率(RR/RP为53.1%,PP为14.3%;p<0.05)方面存在显著差异。
本研究表明,在反复种植失败和复发性流产患者中,p53基因的R72P比可育人群更普遍。此外,携带p53密码子72的PP基因型的患者持续妊娠的机会较少。这些信息以及一些其他标志物将有助于开发诊断测试,以便在开始不孕治疗之前检测反复种植失败和复发性流产的风险。